Skip to main content

Experience with Private Equity Involvement in IVF Clinics: The Good, The Bad, The Ugly

Edited by:

Paula Amato, MD, Oregon Health & Science University, United States 
Tarun Jain, MD, Northwestern Medicine, United States
 

Submission Status: Open   |   Submission Deadline: 11 March 2026 
 

Reproductive Biology and Endocrinology is calling for submissions to our Collection on Experience with Private Equity Involvement in IVF Clinics: The Good, The Bad, The Ugly.


Image credit: © Eva Blanco

New Content Item This Collection supports and amplifies research related to SDG 3: Good Health & Well-Being and SDG 10, Reduced Inequality.

About the Collection

This collection aims to explore the multifaceted impact of private equity (PE) involvement in IVF clinic operations. The rationale behind this investigation is to understand how the infusion of PE capital influences various aspects of fertility treatments, including patient care, research quality, and overall clinic performance. By examining both the positive and negative outcomes, this collection seeks to provide a balanced perspective on the role of PE in the healthcare sector.

We invite submissions of original research articles and review papers addressing issues such as:

•       Assessment of the metrics used to measure patient care and research quality in IVF clinics under PE management. This includes key performance indicators (KPIs), patient satisfaction surveys, and clinical outcomes

•       The role of PE in providing financial stability and enabling technological advancements in IVF clinics.

•       Potential in patient care and research quality due to profit-driven motives.

•       Mixed reactions from patients and healthcare providers regarding the corporate approach to fertility treatments

•       Examination of how PE influences the cost of IVF treatments and how it affects equity in access to fertility care.

By exploring these topics, this collection aims to offer a comprehensive understanding of the implications of PE involvement in IVF clinics, highlighting both the benefits and challenges associated with this model.

Meet the Guest Editors

Back to top

Paula Amato, MD, Oregon Health & Science University, United States 

Dr. Paula Amato is a double-board-certified OB/GYN and Reproductive Endocrinologist with a career focused on Women’s Health. Dr. Amato is a Professor of Obstetrics & Gynecology and Director of the Division of Reproductive Endocrinology & Infertility at Oregon Health & Science University. Dr. Amato served as president of the American Society for Reproductive Medicine from 2023-2024. Dr. Amato specializes in caring for patients with infertility, polycystic ovary syndrome, and menopausal issues. Her research focuses on innovative assisted reproductive technologies for the treatment of infertility and ovarian aging.
 

Tarun Jain, MD, Northwestern Medicine, United States

Dr. Tarun Jain is a Professor at Northwestern University Feinberg School of Medicine & a Medical Director at Northwestern Medicine Fertility & Reproductive Medicine.  He completed his Reproductive Endocrinology & Infertility (REI) fellowship at Brigham & Women's Hospital / Harvard Medical School. Dr. Jain has over 20 years of clinical ART experience in both a private and academic setting and is annually recognized as a Top Doctor by Castle Connolly.  For the past 20 years, he has also been actively involved on numerous national committees of SART/ASRM, including most recently as Chair of the SART Practice Committee.

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original research articles and review papers. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. 

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Experience with Private Equity Involvement in IVF Clinics: The Good, The Bad, The Ugly" under the “Details” tab during the submission stage.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.